These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26055103)

  • 1. Summertime dosage-dependent hypersensitivity to an angiotensin II receptor blocker.
    Forsdyke DR
    BMC Res Notes; 2015 Jun; 8():227. PubMed ID: 26055103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative efficacy and safety profile of amlodipine 5 mg/losartan 50 mg fixed-dose combination and amlodipine 10 mg monotherapy in hypertensive patients who respond poorly to amlodipine 5 mg monotherapy: an 8-week, multicenter, randomized, double-blind phase III noninferiority study.
    Kang SM; Youn JC; Chae SC; Park CG; Yang JY; Kim MH; Hong TJ; Kim CH; Kim JJ; Shin DG; Jeong JW; Yoon JH; Park SH; Kwon J; Cho SY
    Clin Ther; 2011 Dec; 33(12):1953-63. PubMed ID: 22136978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of an angiotensin II receptor blocker on the impaired function of endothelial progenitor cells in patients with essential hypertension.
    Suzuki R; Fukuda N; Katakawa M; Tsunemi A; Tahira Y; Matsumoto T; Ueno T; Soma M
    Am J Hypertens; 2014 May; 27(5):695-701. PubMed ID: 24200748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effect of switching from a combination of angiotensin II receptor blockers other than losartan and thiazides to a fixed dose of losartan/hydrochlorothiazide on uric acid metabolism in hypertensive patients.
    Ohshiro K; Sakima A; Nakada S; Kohagura K; Yamazato M; Tana T; Ohya Y
    Clin Exp Hypertens; 2011; 33(8):565-70. PubMed ID: 21958001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide.
    Abe M; Okada K; Matsumoto K
    Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1285-303. PubMed ID: 19761411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Switching therapy from variable-dose multiple pill to fixed-dose single-pill combinations of angiotensin II receptor blockers and thiazides for hypertension.
    Sakima A; Ohshiro K; Nakada S; Yamazato M; Kohagura K; Nakamoto M; Tana T; Ohya Y
    Clin Exp Hypertens; 2011; 33(5):309-15. PubMed ID: 21649528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy and safety of fixed-dose amlodipine/losartan and losartan in hypertensive patients inadequately controlled with losartan: a randomized, double-blind, multicenter study.
    Hong BK; Park CG; Kim KS; Yoon MH; Yoon HJ; Yoon JH; Yang JY; Choi YJ; Cho SY
    Am J Cardiovasc Drugs; 2012 Jun; 12(3):189-95. PubMed ID: 22462558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of combination therapy with losartan/hydrochlorothiazide on the relationships between base blood pressure, autonomic function, and health-related QOL].
    Okano Y; Toya Y; Azuma K; Yabana M; Tamura K; Umemura S
    Nihon Jinzo Gakkai Shi; 2010; 52(7):939-44. PubMed ID: 21077345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of the combination of amlodipine and losartan for lowering blood pressure in spontaneously hypertensive rats.
    Choi SM; Seo MJ; Kang KK; Kim JH; Ahn BO; Yoo M
    Arch Pharm Res; 2009 Mar; 32(3):353-8. PubMed ID: 19387578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent effects on blood pressure and renal function of perindopril alone or combined with losartan in Lyon hypertensive rats.
    Naelten G; Liu KL; Chapuis B; Lo M
    Am J Hypertens; 2005 May; 18(5 Pt 1):699-706. PubMed ID: 15882554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of long-term losartan therapy demonstrated by a prospective observational study in Japanese patients with hypertension: The Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study.
    Naritomi H; Fujita T; Ito S; Ogihara T; Shimada K; Shimamoto K; Tanaka H; Yoshiike N
    Hypertens Res; 2008 Feb; 31(2):295-304. PubMed ID: 18360050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-grade inflammation and ambulatory blood pressure response to antihypertensive treatment: the ALPHABET study.
    Fukutomi M; Hoshide S; Eguchi K; Watanabe T; Kario K
    Am J Hypertens; 2013 Jun; 26(6):784-92. PubMed ID: 23446957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The safety of long-term administration of losartan in current clinical practice: a non-intervention NCT-CZ 14/04/LOZ study].
    Krupicka J; Ceypová K; Kristenová P; Hauser T
    Vnitr Lek; 2008 Nov; 54(11):1031-8. PubMed ID: 19069675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of home blood pressure measurement for preventing stroke and cardiovascular disease in hypertensive patients: a sub-analysis of the Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study, a prospective nationwide observational study.
    Shimada K; Fujita T; Ito S; Naritomi H; Ogihara T; Shimamoto K; Tanaka H; Yoshiike N
    Hypertens Res; 2008 Oct; 31(10):1903-11. PubMed ID: 19015598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential impact of angiotensin receptor blockers and calcium channel blockers on arterial stiffness.
    Andreadis EA; Sfakianakis ME; Tsourous GI; Georgiopoulos DX; Fragouli EG; Katsanou PM; Tavoularis EI; Skarlatou MG; Marakomichelakis GE; Ifanti GK; Diamantopoulos EJ
    Int Angiol; 2010 Jun; 29(3):266-72. PubMed ID: 20502415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of brain angiotensin II type 1 receptor inhibits the development of atrial fibrillation in hypertensive rats.
    Nagayama T; Hirooka Y; Kishi T; Mukai Y; Inoue S; Takase S; Takemoto M; Chishaki A; Sunagawa K
    Am J Hypertens; 2015 Apr; 28(4):444-51. PubMed ID: 25352232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
    Petrella R; Michailidis P
    Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy of angiotensin II receptor blocker and calcium channel blocker exerts pleiotropic therapeutic effects in addition to blood pressure lowering: amlodipine and candesartan trial in Yokohama (ACTY).
    Maeda A; Tamura K; Kanaoka T; Ohsawa M; Haku S; Azushima K; Dejima T; Wakui H; Yanagi M; Okano Y; Fujikawa T; Toya Y; Mizushima S; Tochikubo O; Umemura S
    Clin Exp Hypertens; 2012; 34(4):249-57. PubMed ID: 22571446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker.
    Furuhashi M; Moniwa N; Mita T; Fuseya T; Ishimura S; Ohno K; Shibata S; Tanaka M; Watanabe Y; Akasaka H; Ohnishi H; Yoshida H; Takizawa H; Saitoh S; Ura N; Shimamoto K; Miura T
    Am J Hypertens; 2015 Jan; 28(1):15-21. PubMed ID: 24842388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.